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Neutral and anionic scorpionate ligands have been employed to generate active-site models of 
hydroquinone dioxygenases (HQDOs). While the nonheme Fe center in nearly all HQDOs is coordinated 
to one Asp (or Glu) and two His residues, 1,2-gentisate dioxygenase (GDO) is unique in featuring a 
three His triad instead. A synthetic GDO model was therefore prepared with the neutral tris(4,5-
diphenyl-1-methylimidazol-2-yl)phosphine (Ph2TIP) ligand. The gentisate substrate was mimicked with 
the bidentate ligand 2-(1-methylbenzimidazol-2-yl)hydroquinonate (BIHQ). X-ray diffraction analysis of 
the resulting complex, [Fe(Ph2TIP)(BIHQ)]OTf (1a), revealed a distorted square-pyramidal geometry. 
Structural and electrochemical data collected for 1a were compared to those previously reported for 
[Fe(Ph2Tp)(BIHQ)] (1b), which features an anionic hydridotris(3,5-diphenylpyrazol-1-yl)borate (Ph2Tp) 
ligand. Oxidation of 1a and 1b provides the corresponding FeIII complexes (2a/2b) and the crystal 
structure of 2b is reported. Both complexes undergo reversible deprotonation to yield the brown 
chromophores, 3a and 3b. Detailed studies of 3a and 3b with spectroscopic (UV/Vis absorption, EPR, 
resonance Raman) and computational methods determined that each complex consists of a high-spin 
FeII center ferromagnetically coupled to a p-semiquinonate radical (BISQ). The (de)protonation-induced 
valence tautomerization described here resembles key steps in the putative HQDO mechanism. 
Abstract 
Both neutral and anionic scorpionates are used to prepare synthetic models of hydroquinone 
dioxygenases (HQDOs) – a class of mononuclear nonheme enzymes. The different ligands mimic 
variations in coordination geometry within the HQDO family. The ferric-hydroquinonate complexes 
undergo reversible deprotonation to yield ferrous-semiquinonate species. 
 
I. Introduction 
The facially capping ligands known as “scorpionates” have been applied to nearly every aspect of 
coordination chemistry, including the preparation of synthetic metalloenzyme models.1 Lippard and 
co-workers were the first to harness the biomimetic potential of this ligand family when they modeled 
the diiron active site of hemerythrin using Trofimenko's original scorpionate, hydridotris(pyrazol-1-
yl)borate {Tp = [HB(pz)3]–}.2 Soon thereafter, the emergence of second-generation RTp 
ligands3 featuring an alkyl or aryl substituent at the pyrazole 3-position (Scheme 1) triggered an 
explosion of Tp-based metalloenzyme models, which has continued unabated for the past 30 years. 
The flexibility and robust nature of the [HB(X)3]– framework has also encouraged the development of 
Tp-variants in which the pyrazole donors are replaced by thioimidazoles,4 N-heterocyclic 
carbenes,5 triazoles,6 or other heterocycles.7 Fifty years after their discovery, scorpionates have a 




Second-generation RTp ligands are commonly used to mimic histidine-rich active sites that exhibit facial 
coordination at the metal ion(s); prominent examples include carbonic anhydrase,8 copper-containing 
amine oxidase,9 hemocyanin,10 and copper nitrite reductases11 (just to name a few). Scorpionates are 
also well-suited for biomimetic studies of mononuclear nonheme iron dioxygenases (MNIDs), which 
catalyze the incorporation of both atoms of O2 into a wide variety of substrates.12 The vast majority of 
MNIDs contain a high-spin FeII center bound by one Asp (or Glu) and two His residues in a facial 
orientation – the 2-His-1-carboxylate (2H1C) facial triad.13 Numerous studies have employed the RTp 
scaffold to replicate the monoanionic charge, facial arrangement, and ligand-field strength of the 2H1C 
triad.14 Other chemists have prepared N,N,O-heteroscorpionates with one carboxylate and two 
nitrogen donors to more accurately reproduce the enzymatic ligand set.15 
Given the prevalence of the 2H1C coordination motif among MNIDs, it was rather surprising when two 
crystal structures of mammalian cysteine dioxygenase (CDO), published in 2006, revealed a 
mononuclear iron site with a neutral 3-histidine (3His) facial triad instead.16 Other members of the 
“3His family” were subsequently reported and structurally characterized, including β‐diketone 
dioxygenase (Dke1),17 salicylate 1,2-dioxygenase (SDO),18 and gentisate 1,2-dioxygenase (GDO).19 Of 
particular relevance to this manuscript is GDO, which catalyzes the oxid-ative cleavage of the C1–C2 
bond within the hydroquinone ring of its substrate (Scheme 2).20 Interestingly, GDO is the only known 
example of a hydroquinone dioxygenase (HQDO) featuring the 3His triad;21 all other HQDOs, including 




The HQDO family is unique in containing both 2H1C and 3His enzymes, and the catalytic implications of 
this variation in first-sphere coordination environment are unclear at the present. Biomimetic studies 
involving both neutral and anionic scorpionates have the potential to elucidate the role of the facial 
triad in tuning the electronic structure of nonheme iron sites. In 2012, we reported a series of HQDO 
model complexes using the hydridotris(3,5-diphenylpyrazol-1-yl)borate (Ph2Tp) supporting ligand to 
mimic the 2H1C triad found in most HQDOs.23 Each complex featured a mono- or bidentate 
hydroquinonate (HQate) ligand attached to the [Fe2+(Ph2Tp)]+ scaffold, thereby replicating the structure 
of substrate-bound HQDOs in which the deprotonated HQ coordinates directly to iron. The discovery of 
a 3His triad in the GDO active site has since prompted us to prepare HQDO models using a neutral, 
imidazole-based scorpionate ligand, specifically, tris(4,5-diphenyl-1-methylimidazol-2-yl)phosphine 
(Ph2TIP; Scheme 1). Tris(imidazolyl)phosphine ligands were initially developed in the 1980s to model the 
active sites of Zn and Cu enzymes.24 Our previous spectroscopic studies of Dke1 models found that TIP 
ligands accurately reproduce the coordination environment and donor strength of the 3His triad, 
whereas the properties of Tp ligands align better with the 2H1C triad.25 The Ph2Tp- and Ph2TIP-based 
complexes are therefore complimentary models of the two types of HQDO active sites. 
This manuscript describes the synthesis and X-ray crystal structure of [Fe(Ph2TIP)(BIHQ)]OTf {1a, where 
BIHQ is the monoanion of 2-(1-methyl-1H-benzimidazol-2-yl)hydroquinone; Scheme 3}. The BIHQ 
ligand forms a six-membered chelate ring upon metal binding, which resembles the bidentate 
coordination of gentisate to iron in the GDO mechanism. The structural and electrochemical properties 
of 1a are then compared to those previously reported for [Fe(Ph2Tp)(BIHQ)] (1b in Scheme 3; Ph2TIP-
based complexes are labeled Xa and Ph2Tp-based complexes are labeled Xb). In addition, we have 
explored the ability of these complexes to perform proton- and electron-transfers via stepwise or 
concerted processes. For 1a and 1b, one-electron oxidation generates the corresponding FeIII-HQate 
complexes 2a and 2b. Interestingly, both 2a and 2b undergo reversible deprotonation to yield 
metastable species (3a and 3b, respectively) in which the FeII center is bound to a p-semiquinonate 
(pSQ·–) radical. The existence of this proton-induced valence tautomerization has been confirmed 
through extensive spectroscopic and computational studies. Complexes 3a and 3b serve as a models of 
the elusive FeII-pSQ·– intermediate proposed for the enzymatic mechanisms of HQDOs.26 Moreover, 
the pairs of valence tautomers highlight the interplay of “noninnocent” behavior and protonation state 




II. Results and Discussion 
1. Preparation, Solid-State Structures, and Electrochemical Properties 
Complex 1a was synthesized by the reaction of [Fe(Ph2TIP)(MeCN)3](OTf)227 with an equimolar amount 
of Na(BIHQ) salt in THF. Yellow crystals, of sufficient quality for X-ray diffraction (XRD) analysis, were 
grown by vapor diffusion of diethyl ether into a concentrated 1,2-dichloroethane (DCE) solution. The 
asymmetric unit of the X-ray structure consists of the cationic monoiron complex, the triflate 
counteranion, and two Et2O solvates. As shown in Figure 1 (a), the five-coordinate (5C) FeII center 
of 1a is attached to a facially capping Ph2TIP ligand and bidentate BIHQ anion. The distorted 
coordination geometry is intermediate between square-pyramidal and trigonal-pyramidal. The two 
rings of the BIHQ chelate are rotated by 27° with respect to each other, largely to accommodate the π–
π stacking interaction between the benzimidazole unit and a nearby 4-phenyl substituent of Ph2TIP. The 
distal –OH moiety of BIHQ forms a hydrogen bond with one of the Et2O solvates. 
 
Figure 1 (a) Thermal ellipsoid plot (50 % probability) obtained from the X‐ray crystal structure of 1a. The phenyl 
rings at the 5-positions of the Ph2TIP ligand have been omitted for clarity, as well as non-coordinating solvent 
molecules and most hydrogen atoms. (b) Overlays of the crystallographically derived structures 
of 1a (white), 1b (orange), and 2b (magenta). The phenyl and methyl substituents of the Ph2Tp and Ph2TIP ligands 
are not shown. 
 
The Fe–NTIP bond lengths of 1a range from 2.11 Å for N3 to 2.22 Å for the pseudo-axial N5 donor 
(Table 1). The anionic BIHQ ligand exhibits Fe1–O1 and Fe1–N7 distances of 1.91 and 2.15 Å, 
respectively, typical of phenolate28 and benzimid-azole29 donors in high-spin ferrous complexes. The 
observed magnetic moment of µeff = 4.93 µB at room temperature (r.t.) is also proof that 1a possesses 
a high-spin (S = 2) FeII center. 
Table 1. Selected bond lengths [Å] and bond angles [°] for complexes 1a, 1b, and 2b as measured by X-
ray crystallography 
Bond lengths 1a 1b a 2b 
Fe–N1 2.1681(12) 2.1218(14) 2.0409(17) 
Fe–N3 2.1149(12) 2.1481(15) 2.0464(18) 
Fe–N5 2.2214(12) 2.1470(15) 2.1138(17) 
Fe–O1 1.9144(10) 1.9609(12) 1.8292(15) 
Fe–N7 2.1503(13) 2.1393(15) 2.0693(17) 
Fe–NTp/TIP (ave) 2.168 2.139 2.067 
Fe–L (ave) 2.114 2.103 2.020 
O1–C1 1.321(2) 1.341(2) 1.337(2) 
O2–C4 1.377(2) 1.370(2) 1.373(3) 
C1–C2 1.423(2) 1.417(2) 1.412(3) 
C1–C6 1.409(2) 1.405(2) 1.399(3) 
C2–C3 1.410(2) 1.410(2) 1.403(3) 
C3–C4 1.380(2) 1.379(2) 1.384(3) 
C4–C5 1.393(2) 1.397(2) 1.390(3) 
C5–C6 1.385(2) 1.383(2) 1.376(3) 
C–C (ave) 1.400 1.399 1.394 
C–C (dev) b 0.017 0.015 0.013 
Bond angles 
   
O1–Fe–N1 117.31(5) 110.64(5) 115.58(7) 
O1–Fe–N3 147.79(5) 153.34(5) 147.84(7) 
O1–Fe–N5 98.33(4) 94.78(5) 94.80(7) 
O1–Fe–N7 88.20(5) 88.90(5) 88.92(7) 
N1–Fe–N3 94.87(5) 95.65(6) 96.52(7) 
N1–Fe–N5 88.04(5) 92.11(5) 90.95(7) 
N1–Fe–N7 89.69(5) 90.69(6) 91.19(7) 
N3–Fe–N5 83.23(5) 79.38(6) 82.10(7) 
N3–Fe–N7 90.82(5) 95.37(6) 92.54(7) 
N5–Fe–N7 173.42(5) 174.27(6) 174.42(7) 
τ-value c 0.43 0.35 0.44 
a The structure of 1b was originally reported in ref.22 
b This number reflects the standard deviation of C–C bond lengths. 
c See ref.29 for the definition of the τ-value. 
 
Table 1 compares the metric parameters of Ph2TIP-based 1a to those previously reported for Ph2Tp-
based 1b. The coordination geometries of the two complexes are quite similar, as evident in the 
overlay of solid-state structures shown in Figure 1 (b). The 1b structure falls somewhat closer to the 
square-pyramidal limit than 1a, as indicated by the respective τ-values30 of 0.35 and 0.43 (Table 1). 
The average Fe–NTIP bond length in 1a is about 0.03 Å longer than the average Fe–NTp bond length 
in 1b, in line with our previous comparisons of FeII Tp/TIP pairs.25, 31 
The redox properties of 1a were examined using electrochemical methods in CH2Cl2 solution with 
0.1 m [NBu4]PF6 as the supporting electrolyte. All redox potentials are referenced to the ferrocene 
(Fc+/0) couple. Two features are evident in the cyclic voltammogram (CV): a quasi-reversible couple at –
190 mV (ΔE = 200 mV) and an irreversible oxidation at Ep,a = 950 mV (Figure 2). Based on our prior 
experience with 1b and related complexes, the lower-potential event is assigned to the Fe2+/3+ couple, 
while the high-potential peak is attributed to oxidation of the BIHQ ligand.23, 25, 31 CV data obtained 
for 1b is provided in Figure 2 for the sake of comparison. The Fe2+/3+ potential of 1a is shifted positively 
by 100 mV relative to 1b due to the weaker donor strength of neutral Ph2TIP relative to anionic Ph2Tp. 
 
Figure 2 Cyclic voltammograms of 1a and 1b in CH2Cl2 (c = 2.0 mm) with 0.1 m (NBu4)PF6 as the supporting 
electrolyte. 
 
On the basis of the CV data, we sought to isolate the ferric complexes 2a and 2b using chemical means 
of oxidation. To this end, treatment of the yellow FeII complexes with one equivalent of a ferrocenium 
(Fc+) salt in CH2Cl2 gives rise to dark brown chromophores with intense absorption bands in the visible 
region (Figure 3). The spectrum of 2a exhibits a broad feature with λmax = 630 nm (ε = 2600 m–1 cm–1), 
while 2b displays two intense, overlapping bands between 400 and 600 nm. These features likely arise 
from phenolate-to-FeIII charge transfer (CT) transitions.32 Indeed, both complexes exhibit EPR signals 
characteristic of rhombic, high-spin FeIII centers; namely, an intense derivative-shaped feature at g = 
4.3 and a much weaker peak at g = 9.4 (Figure 4 and S1). 
 
Figure 3 UV/Visible absorption spectra measured in CH2Cl2. The red spectra of 3a/3b were obtained by treating 
solutions of 2a/2b (black solid lines) with 5 equiv. of NEt3 at –30 °C and r.t., respectively. The black spectra 
of 3a/3b (dashed lines) were collected after treating solutions of 1a/1b with one equiv. of the TTBP· radical at 
room temp. 
 
Figure 4 X-band EPR spectra of 2a (red line) and 3a (black line) in frozen CH2Cl2 solution ([Fe] = 1.4 mm) at 15 K. 
The intensity of the 2a spectrum has been reduced by 50 %. The feature labeled with an asterisk (*) in 
the 3a spectrum arises from residual 2a. The simulated 3a spectrum (grey line) was obtained with the following 
parameters: D = 0.63 cm–1, E/D = 0.03, and g = 2.02, 2.0, 2.0. 
 
Crystals of 2b suitable for XRD studies were generated by oxidation with [Fc]PF6, followed by diffusion 
of pentane into a concentrated DCE solution (to date, we have not been able to grow crystals 
of 2a with any counteranion). Metric parameters derived from the resulting crystal structure are 
shown in Table 1. Complex 2b retains the five-coordinate geometry of its ferrous precursor, as 
illustrated by the high degree of overlap between the 1b and 2b structures depicted in Figure 1 (b). The 
presence of the distal –OH moiety of BIHQ is evident from the hydrogen bond it forms with the 
PF6– counteranion. Compared to 1b, the average Fe–NTp and Fe–O1 bond lengths in 2b are contracted 
by 0.07 and 0.13 Å, respectively, while the O–C and C–C distances of the BIHQ ligand are unchanged 
within experimental error (Table 1). Therefore, the XRD data confirm that conversion 
of 1b into 2b involves an iron-centered oxidation, and there is no detectable amount of radical 
character on the BIHQ ligand. Although XRD data is lacking for 2a, the spectroscopic results (vide supra) 
indicate that this complex also contains an FeIII center bound to a HQate ligand. 
2. Formation and Spectroscopic Features of 3a and 3b 
Treatment of complexes 2a and 2b with 5–10 equiv. of triethylamine in CH2Cl2 immediately yields the 
golden-brown chromophores 3a and 3b, respectively (Figure 3). The absorption spectra of the new 
species are nearly identical, with each displaying three bands of increasing intensity at 540, 440, and 
370 nm. The reaction is reversible, as addition of excess acid (HBF4) to solutions of 3a/3b regenerates 
the 2a/2b spectra with only 15 % reduction in intensity (Figure S2). Given the structure of the 
FeIII complexes, it is reasonable to assume that the 2a/b → 3a/b conversion involves deprotonation of 
the distal –OH group of the BIHQ ligand. In support of this conclusion, 3a and 3b can also be prepared 
by treatment of the ferrous precursors (1a and 1b) with 2,4,6-tri-tert-butylphenoxy radical (TTBP·) – a 
well-established H-atom transfer (HAT) agent (Figure 3).33 Thus, the three complexes in each series 
(1a/1b, 2a/2b, 3a/3b) can be interconverted by concerted or stepwise transfers of one electron and/or 




Bases other than NEt3 were used in an attempt to estimate the pKa of 2a and 2b. For both complexes, 
addition of the weaker base 2,6-lutidine in CH2Cl2 failed to generate the corresponding 3a/3b species. 
Similar results were observed for 2a in MeCN solutions, where the pKa-values of triethylammonium 
(HNEt3+) and 2,6-lutidinium (2,6-LutH+) are known to be 18.6 and 14.0, respectively.34 Bordwell and 
Mayer have proven that the bond dissociation free energy (BDFE) of an X–H bond is a function of both 
pKa and redox potential (E°), according to the following equation: BDFE (X–H) = 1.37 pKa + 23.06 E° 
+ CG,solv, where CG,solv is a solvent‐dependent constant equal to 54.9 kcal mol–1 in MeCN.35 Using the 
experimental redox potential, and assuming a pKa-value halfway between HNEt3+ and 2,6-LutH+, 
provides a BDFE of 72.9 kcal mol–1 for 1a. This bond energy is reasonable given that 1a transfers a H-
atom to TTBP· (BDFE = 77.1 kcal mol–1) but not to the TEMPO· radical (BDFE = 66.5 kcal mol–1; all values 
in MeCN).35 
Unfortunately, it was not possible to grow crystals of 3a or 3b for XRD studies; therefore, electronic-
structure insights were gathered using spectroscopic methods, in conjunction with the DFT calculations 
described in the next section. Two limiting descriptions are possible: 3a/3b could consist of an 
FeIII center bound to a closed-shell hydroquinonate dianion (HQate2–), or an FeII center bound to a p-
semiquinonate radical anion (pSQ·–). Significantly, the UV/Vis absorption spectra of 3a/3b closely 
resemble those published for para- and ortho-semiquinone radicals in various contexts.36 For 
example, our group recently prepared a Ph2Tp-based FeII complex that features a 1,4-
naphthosemiquinone ligand. This complex displays a three-band pattern between 380 and 560 nm 
with intensities very similar to those observed for 3a/3b.[36] Transient absorption studies of “free” p-
semiquinones likewise report a series of π–π* transitions in the near‐UV region.37 Indeed, the close 
similarity of the 3a and 3b spectra suggests that the observed transitions are primarily ligand-based – a 
hypothesis supported by time-dependent DFT calculations (vide infra). 
EPR samples of 3a and 3b were prepared via stepwise oxidation and deprotonation of 1a/1b. 
Interestingly, it was observed that CH2Cl2 solutions of 3b change color from golden-brown to green 
upon freezing, whereas 3a maintains its brown color at all temperatures. Variable-temperature 
absorption studies found that the 440 and 540 nm bands of 3b diminish as the temperature is lowered 
to –70 °C, while a new chromophore (labeled 4b) appears with a broad band at λmax = 825 nm. This 
thermochromic behavior is reversible, as 4b converts back to 3b when the temperature is returned to 
25 °C (Figure S3). The EPR spectrum of 4b measured at 15 K is featureless apart from a weak peak 
at g = 4.3 due to residual 2b (Figure S1). While further studies are required, we postulate that 4b arises 
from dimerization of 3b at low temperatures, which would yield the EPR-silent species observed 
experimentally. 
Thankfully, the absence of thermochromism for 3a indicates that the structure of this complex is 
maintained upon freezing. Unlike 4b, complex 3a exhibits an intense EPR signal at 10 K with features 
at g = 6.55, 5.32, and 1.98, along with a small derivative at g = 4.3 from residual 2a (Figure 4). This 
spectrum is characteristic of an S = 5/2 paramagnet with an axial D-tensor; the data was nicely 
simulated with spin-Hamiltonian parameters of g = 2.02, 2.0, 2.0; D = 0.63 cm–1, E/D = 0.03 (Figure 4; 
where D and E are the axial and rhombic zero-field splitting parameters, respectively). Given the 
rhombic nature of the 2a spectrum (E/D ≈ 0.33) noted above, the EPR results make it clear that 
the 2a → 3a conversion causes a dramatic rearrangement of unpaired spin-density within the S = 5/2 
manifold. The origin of this change has been elucidated with the aid of DFT calculations described in 
the next section. 
3. Geometric and Electronic Structures of DFT-Optimized Models 
Table 2 provides relevant metric parameters for energy-minimized structures of complexes 2b, 3a, 
and 3b obtained via DFT geometry optimizations. Truncated versions of the complexes were employed 
in which the Ph rings at the 5-positions of the Ph2Tp and Ph2TIP ligands were removed. Unless otherwise 
noted, all calculations employed the hybrid B3LYP functional and assumed a S = 5/2 ground state. The 
accuracy of our computational approach was gauged by comparing the XRD and DFT structures of 
complex 2b. While DFT slightly overestimates the FeIII–N/O bond lengths (by 0.05 Å on average), it 
accurately reproduces the C–C and O–C bond lengths of the HQate ligand, with a root-mean-square 
deviation of only 0.01 Å (i.e., near the experimental 3σ error of the XRD measurement). We therefore 
felt confident in proceeding with calculations of 3a and 3b, for which structural data are lacking. 
Table 2. DFT-calculated bond lengths [Å] for models of 2a, 3a, 3b, and the BISQ radical 
 
2b 3b Δ a 3a Free BISQb 
Bond distances      
Fe–N1 2.110 2.180 0.070 2.214 
 
Fe–N3 2.084 2.177 0.093 2.186 
 
Fe–N5 2.162 2.250 0.088 2.348 
 
Fe–O1 1.861 1.982 0.121 1.952 
 
Fe–N7 2.152 2.190 0.038 2.185 
 
Fe–L (av.) 2.074 2.156 0.082 2.177 
 
O1–C1 1.320 1.293 –0.027 1.303 1.327 
O2–C4 1.360 1.256 –0.104 1.254 1.253 
C1–C2 1.421 1.444 0.023 1.438 1.441 
C1–C6 1.409 1.432 0.023 1.428 1.416 
C2–C3 1.404 1.386 –0.018 1.386 1.383 
C3–C4 1.388 1.442 0.054 1.441 1.444 
C4–C5 1.401 1.448 0.047 1.448 1.447 
C5–C6 1.409 1.361 –0.048 1.362 1.362 
C–C (av.) 1.400 1.419 0.019 1.417 1.416 
C–C (dev.)c 0.016 0.036 
 
0.035 0.036 
Mulliken spins      
Fe 4.14 3.81 –0.33 3.80 – 
O,N-ligand 0.34 1.09 +0.75 1.13 1.04 
a Difference between corresponding 2b and 3b bond lengths. 
b Geometry-optimized model of the BISQ radical (H-atom removed from the 4-OH position). 
c Standard deviation of the six C–C bond lengths within the BIHQ or BISQ ring. 
 
The structural differences between 2b and 3b/3a are highlighted in Table 2. The iron-ligand bonds 
in 3b are longer than their counterparts in 2b by an average of 0.082 Å; indeed, the computed Fe–L 
distances in 3a and 3b are more similar to those observed experimentally for the 
FeII complexes 1a/1b.38 The bidentate O,N-ligand derived from BIHQ also experiences sizeable 
changes. The closed-shell nature of the HQate donor in 2b is evident in the uniformity of its six C–C 
bond lengths (standard deviation of 0.016 Å). In the 3a and 3b models, however, this deviation 
increases to 0.035 Å and the C–C bonds display the “four long/two short” pattern characteristic of 
semiquinones.39 This quinoidal-type distortion is also apparent in the dramatic shortening of the O2–
C4 bond from 1.360 Å in 2b to ca. 1.255 Å in 3a/3b. Significantly, the metric parameters of the 
bidentate O,N-ligand in 3a/3b are very similar to those computed for the “free” 2-(1-
methylbenzimidazol-2-yl)semiquinone radical (BISQ·; Table 2). Collectively, the DFT results indicate that 
deprotonation of the distal –OH moiety triggers an electron transfer (ET) from BIHQ to the Fe center, 
giving rise to an FeII-BISQ configuration. This conclusion is further supported by the Mulliken spin 
populations of the Fe center (3.8 α spins) and BISQ ligand (1.1 α spins) in the 3a/3b models (Table 2). 
DFT calculations of 3b were used to generate the molecular orbital (MO) diagram shown in Figure 5. 
The most critical orbitals for evaluating the electronic configuration of this complex are the frontier 
MOs in the spin‐down (β) manifold. The highest‐occupied β MO (203β) possesses 81 % Fe character 
with electron density primarily located in the Fe dyz orbital, confirming the presence of a high-spin 
FeII ion. By contrast, the lowest‐unoccupied β MO (204β) has 84 % ligand character localized in a π*‐
orbital on the pSQ·– unit, clear evidence of a ligand-based radical. Ferromagnetic coupling between the 
FeII center (S = 2) and BISQ radical (S = 1/2) yields the axial S = 5/2 paramagnet observed in the EPR 
spectrum of 3a. 
 
Figure 5 Energy‐level diagram for the spin‐down (β spin) MOs obtained from an unrestricted DFT calculation 
of 3a. MOs are labeled according to their principal contributor. Surface contour plots for the highest-occupied 
and lowest-unoccupied orbitals are also shown. 
 
The time-dependent DFT (TD-DFT) approach was employed to compute the absorption spectrum of 3a. 
As shown in Figure 6, the calculated spectrum adequately reproduces the energies and intensities of 
the experimental absorption features, suggesting that our DFT model of 3a provides an accurate 
description of the complex's electronic structure. Analysis of the computed transitions indicate that the 
lowest-energy feature near 550 nm arises from an FeII→BISQ charge transfer (CT) transition, while the 
higher-energy peaks (350 nm < λmax < 450 nm) are due to BISQ‐based π→π* transitions. These findings 
are consistent with our prior studies of a monoiron(II) complex containing a 1,4-naphthosemiquinone 
ligand.[36] 
 
Figure 6 Experimental (black dashed line) and TD-DFT computed (solid red line) absorption spectra of 3a. The 
experimental spectrum was obtained by treating 1a with the TTBP· radical in CH2Cl2. The red sticks mark the 
wavelengths and intensities of computed transitions. 
 
To ensure that our computational results were not simply due to our chosen methodology, we also 
performed parallel calculations of 3a and 3b with the non‐hybrid Becke–Perdew 86 functional (BP). As 
shown in Table S1, the ligand metric parameters of the BP optimized structures are nearly identical to 
those obtained with B3LYP (rms deviation of 0.009 Å), although the Fe–N/O distances computed by BP 
are shorter by ca. 0.04 Å on average. Importantly, the bonding descriptions and spin-density 
distributions provided by the BP calculations are indicative of an FeII-BISQ electronic configuration 
for 3a/3b, in agreement with the B3LYP results. 
4. Resonance Raman Spectroscopic Studies 
The electronic structures of complexes 3a and 3b were further examined with resonance Raman (rR) 
spectroscopy – a well-established method for the characterization of semiquinone radicals.40 The 
experiments employed 457.9 nm laser excitation, in resonance with the ligand‐based π–π* transition 
observed near 440 nm. Spectra of 3b and its 2b precursor were measured at 273 K due to the 
thermochromic nature of the former complex (vide supra), whereas the 3a spectrum was collected at 
77 K on a frozen sample. Figure 7 highlights the 1200–1700 cm–1 region where peaks due to aromatic 
C–C and O–C stretching modes are typically found. The 3a and 3b spectra exhibit an intense feature 
near 1527 cm–1 that is not apparent in the 2a spectrum, and it arises regardless of the route of 
preparation (concerted H-atom transfer or sequential oxidation/deprotonation). A series of peaks is 
also evident between 1400 and 1500 cm–1, especially in the low-temperature 3a spectrum. 
 
Figure 7 Resonance Raman spectra obtained with 457.9 nm excitation (40 mW at sample) of 2b, 3a, and 3b in 
CD2Cl2 solutions. The 3a sample was prepared by treatment of the 1a precursor with TTBP·. The rR spectrum 
of 3a (black line) was collected at 77 K. Samples of 3b were prepared via two routes: treatment of 1b with 
TTBP· (red spectrum) or addition of 5 equiv. of NEt3 to 2b (blue spectrum). rR spectra of 3b and 2b (gray line) 
were measured at 273 K (ice/water bath). 
 
To aid in assignment of the observed rR peaks, DFT frequency calculations were performed for the 
BIHQ ligand in three oxidation states: the hydroquinonate anion (BIHQate; deprotonated at 4-OH 
position), semiquinone radical (BISQ; H-atom removed from 4-OH position), and benzoquinone (BIBQ). 
We focused specifically on the predicted frequency of the distal O–C stretching mode [ν(O2–C4)], since 
studies of ortho‐dioxolene compounds have demonstrated that ν(O–C) modes give rise to intense rR 
peaks that are diagnostic of ligand oxidation state.40 The computed ν(O2–C4)-based mode appears at 
1414 and 1681 cm–1 for BIHQate and BIBQ, respectively, following the expected increase in frequency 
as the ligand becomes more oxidized. The BISQ calculation predicts two modes with significant ν(O2–
C4) character at intermediate frequencies of 1449 and 1521 cm–1. The 1449 cm–1 vibration couples the 
ν(O2–C4) stretch with the breathing motion of the pSQ ring, while the 1521 cm–1 vibration couples the 
ν(O2–C4) stretch to nearby bending motions. Significantly, these calculated ν(O2–C4) frequencies are 
consistent with previous studies of pSQ radicals41 and remarkably close to the experimentally 
observed peaks at 1527 and ca. 1450 cm–1 in the 3a/3b spectra (Figure 7). Thus, the rR data provide 
further evidence that complexes 3a and 3b possess a BISQ ligand. 
III. Summary and Conclusions 
This manuscript has described the preparation and X-ray structural characterization of 
complex 1a (Scheme 3) – the first synthetic model of the nonheme iron enzyme GDO. The 
mononuclear FeII center in the GDO active site is coordinated by a 3His facial triad (Scheme 2), in 
contrast to the 2H1C triad found in all other HQDOs.19 Complex 1a features a neutral Ph2TIP 
scorpionate ligand to mimic the enzymatic 3His triad, while the bidentate BIHQ ligand models the 
coordination of gentisate to the FeII ion. The structural and electrochemical properties of 1a were 
compared to those previously reported for the analogous complex 1b, which contains a 
monoanionic Ph2Tp scorpionate ligand (Scheme 3) that better resembles the 2H1C triad. Overall, the 
differences between 1a and 1b are modest: the Fe–NTIP bonds are longer than the Fe–NTp distances by 
an average of 0.03 Å (Table 1), and the Fe3+/2+ redox potential of 1a is shifted positively by ca. 100 mV 
relative to 1b (Figure 2). Future efforts will examine the comparative O2 reactivities of 1a and 1b to 
ascertain the functional significance of the 3His/2H1C variation for HQDO catalysis. The present work 
further emphasizes the impressive utility of the scorpionate framework – first reported 50 years ago by 
Trofimenko – in biomimetic studies of nonheme iron enzymes. 
Spectroscopic and crystallographic methods confirmed that one-electron oxidation of 1a and 1b yields 
the FeIII-HQate complexes 2a and 2b. Treatment of the FeIII complexes with excess NEt3 gives rise to the 
brown chromophores 3a and 3b, which can also be generated by treatment of 1a/1b with the H-atom 
abstracting agent, TTBP· (Scheme 4). Extensive spectroscopic (UV/Vis, EPR, rR) and computational (DFT) 
studies provided overwhelming evidence that 3a and 3b feature a high-spin FeII center 
ferromagnetically coupled to a pSQ·– ligand (BISQ). Thus, the conversion of 2a/2b → 3a/3b involves 
both deprotonation of the distal hydroxyl group and intramolecular ligand-to-metal ET, as illustrated in 
Scheme 5 (a). The ET occurs because loss of the distal proton destabilizes of the frontier MOs of the 
HQate ligand relative to those of the iron center; indeed, it has been shown that deprotonation of 
free p-hydroquinonate lowers its redox potential by more than 0.9 V in DMSO.35, 42 Keramidas and 
co-workers have similarly demonstrated that tetranuclear vanadium(V) complexes with bridging HQate 
ligands undergo deprotonation to give the corresponding VIV-SQate species.43 Thus, there is literature 




Noninnocent (i.e., redox-active) ligands have garnered increasing attention due to their ability to 
function as electron reservoirs in the cycles of (bio)inorganic catalysts, thereby permitting multi-
electron transformations.44 By comparison, less attention has been paid to ligands, such as HQates, 
that are capable of donating (or accepting) both electrons and protons. The advantage of this type of 
noninnocent ligand is its potential to participate in proton-coupled electron transfers (PCETs), which 
play a critical role in numerous biological and synthetic processes.35, 45 The interconversions 
of 2a/3a and 2b/3b highlight the ability of protonation state to modulate the noninnocent nature of 
ligands such as BIHQ. 
Significantly, this series of complexes (1a/1b, 2a/2b, 3a/3b) replicates key aspects of the proposed 
GDO mechanism, as shown in Scheme 5. The active site of GDO contains a conserved second-sphere 
Asp residue that forms a hydrogen bond to the distal –OH group of the coordinated gentisate 
substrate.19 It has been proposed that this second-sphere carboxylate moiety deprotonates gentisate 
during (or immediately after) O2 binding to the Fe center, thereby giving rise to a superoxo-FeII-
pSQ·– intermediate, see Scheme 5 (b).19, 26 While this intermediate has not been observed 
experimentally, the synthetic results described here suggest that formation of an FeII-
pSQ·– intermediate via transfer of 1e– and 1H+ is a viable option for the GDO catalytic cycle. Of course, 
the complexes 2a/2b and 3a/3b lack the superoxide ligand of the biological intermediates; therefore, 
efforts to generate iron-(semi)quinonate species via direct reaction of 1a/1b with O2 are currently 
underway. 
Experimental Section 
Materials and Physical Methods: Unless otherwise noted, all reagents and solvents were purchased 
from commercial sources and used as received. Solvents CH2Cl2 and MeCN were purified and dried 
using a Vacuum Atmospheres solvent purification system. The synthesis and handling of air-sensitive 
materials were performed under inert atmosphere using a Vacuum Atmospheres Omni-Lab glovebox. 
The compounds ferrocenium hexaflurorphosphate ([Fc]PF6),46 2,4,6-tri-tert-butylphenoxyl radical 
(TTBP·),33 Ph2TIP27 and 2-(1-methylbenzimidazol-2-yl)hydroquinone23 were prepared according to 
published procedures. The syntheses and X-ray crystal structures of complexes 
[Fe(Ph2TIP)(MeCN)3](OTf)2 and 1b were reported previously.23, 27 Elemental analyses were performed 
at Midwest Microlab, LLC in Indianapolis, IN. 
UV/Vis absorption spectra were collected with an Agilent 8453 diode array spectrometer equipped 
with a cryostat from Unisoku Scientific Instruments (Osaka, Japan) for experiments at reduced 
temperatures. Infrared (IR) spectra were measured with a Thermo Scientific Nicolet iS5 FTIR 
spectrometer equipped with the iD3 attenuated total reflectance accessory for solid-state samples. 
EPR experiments were performed using a Bruker EleXsys E650 instrument equipped with an 
ER4415DM cavity, an Oxford Instruments ITC503 temperature controller, and an ESR-900 He flow 
cryostat. The program EasySpin4 was used to simulate the experimental spectra.47 Resonance Raman 
(rR) spectra were measured with 457.9 nm excitation from a Coherent I-305 Ar+ laser using ca. 40 mW 
of power at the sample. The scattered light was collected using a 135° backscattering arrangement, 
dispersed by an Acton Research triple monochromator and detected with a Princeton Instruments 
Spec X 100BR CCD camera. The samples were held in a dewar cooled with either water/ice (273 K) or 
liquid nitrogen (77 K). 
Electrochemical measurements were performed with an epsilon EC potentiostat (iBAS) under nitrogen 
atmosphere at a scan rate of 100 mV/s with 0.1 m (NBu4)PF6 as the electrolyte. A three-electrode cell 
containing a Ag/AgCl reference electrode, a platinum auxiliary electrode, and a glassy carbon working 
electrode was employed for cyclic and square-wave voltammetric measurements. Under these 
conditions, the ferrocene/ferrocenium (Fc+/0) couple has an E1/2 value of +0.52 V in CH2Cl2. 
X-ray diffraction (XRD) data were collected with an Oxford Diffraction SuperNova kappa-diffractometer 
(Agilent Technologies) equipped with dual microfocus Cu/Mo X-ray sources, X-ray mirror optics, Atlas 
CCD detector, and low-temperature Cryojet device. The data were processed with CrysAlis Pro 
program package (Agilent Technologies, 2011), followed by an empirical multi-scan correction using 
SCALE3 ABSPACK routine. Structures were solved using SHELXS program and refined with SHELXL 
program48 within Olex2 crystallographic package.49 X-ray crystallographic parameters are provided in 
Table 3 and experimental details are available in the CIFs. 
Table 3. Summary of X-ray crystallographic data collection and structure refinement 
 
1a·2Et2Oa 2b·C2H4Cl2 
Empirical formula C71H70F3FeN8O7PS C61H49BCl2F6FeN8O2P 
Formula weight 1323.26 1208.61 
Crystal system monoclinic triclinic 
Space group P21/c P 1 
a [Å] 21.2966(19) 12.8542(5) 
b [Å] 20.2553(16) 14.8267(4) 
c [Å] 15.4880(15) 16.1415(5) 
α [deg] 90 75.336(6) 
β [deg] 101.9938(8) 68.675(3) 
γ [deg] 90 88.313(3) 
V [Å3] 6535.20(10) 2765.67(15) 
Z 4 2 
ϱcalcd. [g/cm3] 1.348 1.451 
λ [Å] 1.5418 1.5418 
µ [mm–1] 3.042 3.970 
θ range [deg] 6 to 149 6 to 149 
Reflections collected 63087 52535 
Independent reflections 13122 [Rint = 0.0320] 11084 [Rint = 0.0418] 
Data/restraints/parameters 13122/0/868 11084/0/777 
GOF (on F2) 1.021 1.078 
R1/wR2 [I > 2σ(I)] 0.0348/0.0907 0.0460/0.1234 
Ra/wR2 (all data) 0.0378/0.0932 0.0495/0.1271 
a One of the Et2O solvates is partially (11 %) occupied by 1,2‐dichloroethane solvent. 
 
CCDC 1436476 (for 1a), and 1436477 (for 2b) contain the supplementary crystallographic data for this 
paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre. 
[Fe(Ph2TIP)(BIHQ)]OTf (1a): Under an inert atmosphere, 2-(1-methyl-1H-benzimidazol-2-
yl)hydroquinone (33 mg, 0.14 mmol) was deprotonated by stirring with one equivalent of NaOMe in 
THF. After 30 min, a solution of [Fe(Ph2TIP)(MeCN)3](OTf)2 (165 mg, 0.14 mmol) in THF was added to the 
reaction vial. The mixture was stirred overnight, and the solvent was then removed under vacuum. The 
crude product was taken up in 1,2-dichloroethane and filtered through Celite. Vapor diffusion of Et2O 
into this solution provided yellow crystals suitable for X‐ray diffraction (113 mg, 71 %). 
C63H50F3FeN8O5PS (MW = 1175.02 g mol–1): calcd. C 64.40, H 4.29, N 9.54; found C 63.80, H 4.82, N 
9.04. UV/Vis (CH2Cl2): λmax (ε, m–1 cm–1) = 378 (7800), 440 (2200) nm. FTIR (solid): ν̃ = 3590 [ν(O–H)], 
3047, 2985, 2871, 1604, 1578, 1504, 1488, 1461, 1444, 1386, 1325, 1253, 1155, 1074, 1031, 949, 833, 
638 cm–1. 
[Fe(Ph2Tp)(BIHQ)]PF6 (2b): Complex 1b (149 mg, 0.15 mmol) was treated with one equivalent of 
[Fc]PF6 (50 mg, 0.15 mmol) in MeCN (10 mL) for 30 min. The resulting dark brown solution was filtered 
through Celite to eliminate any unreacted precursor complex, and the solvent was removed under 
vacuum. The resulting brown solid was washed twice with pentane (3 mL each time) to extract the 
ferrocene byproduct. The crude product was then taken up in 1,2-dichloroethane (4 mL), and vapor 
diffusion of pentane into this solution yielded dark brown needles suitable for X-ray crystallography 
(145 mg, 87 %). C59H45BF6FeN8O2P (MW = 1109.68 g mol–1): calcd. C 63.86, H 4.09, N 10.10; found C 
63.49, H 4.25, N 10.05. UV/Vis (CH2Cl2): λmax (ε, m–1 cm–1) = 339 (12800), 441 (6250), 506 (5800) nm. 
FTIR (solid): 3529 [ν(O–H)], 3057, 2987, 2626 [ν(B–H)], 1545, 1479, 1425, 1354, 1255, 1165, 1067, 
1013, 848, 781, 559 cm–1. 
DFT Computations: DFT calculations were performed using the ORCA 3.0 software package developed 
by Dr. F. Neese (MPI for Chemical Energy Conversion).50 Geometry optimizations employed either (i) 
Becke's three-parameter hybrid functional for exchange along with the Lee–Yang–Parr correlation 
functional (B3LYP),51 or (ii) the Becke–Perdew (BP86) functional.52 The coordinates of the geometry-
optimized models are provided in the Supporting Information (Tables S2–S9). All calculations used 
Ahlrichs' valence triple‐ζ basis set (TZV) and TZV/J auxiliary basis set, in conjunction with polarization 
functions on all atoms.53 In the geometry optimized models, the Ph2TIP and Ph2Tp ligands were 
modified by replacing the Ph-groups at the 5-positions of the imidazolyl and pyrazolyl rings, 
respectively, with H-atoms. Time-dependent DFT (TD-DFT) calculations of 3a used a truncated version 
of the optimized model with Me groups (instead of Ph groups) at the 4-positions of the imidazolyl 
rings. TD-DFT calculations54 provided absorption energies and intensities for 60 excited states with the 
Tamm–Dancoff approximation.55 Vibrational frequency calculations were performed on the BIHQ 
ligand in various oxidation states; calculation of the harmonic force fields proved that the optimized 
structure is a local minima on the potential energy surface. Isosurface plots of molecular orbitals and 
electron-density difference maps (EDDMs) were prepared with Laaksonen's gOpenMol program.56 
Supporting Information (see footnote on the first page of this article): DFT-calculated bond lengths 
for 3a and 3b using the BP functional (Table S1), Cartesian coordinates for all geometry-optimized 
structures (Tables S2–S9), and Figures S1–S3. 
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